Guided Care Surveys of Practice Staff, Guided Care Nurses, and Physicians

C10963: Guided Care Surveys of Practice Staff, Guided Care Nurses, and Physicians

Novelty:

Questionnaire evaluating the effect of guided care on health care providers permitting high-quality individualized chronic disease management.

Value Proposition:

Management of chronic diseases requires complex care that is often impeded by the high medical expenses and uncoordinated, provider-centric health care. Guided Care (GC) is a customized health care model to address a patient's unique needs, thereby improving the quality of life of the increasing number of especially elderly people suffering from chronic health conditions. The here-reported guided care surveys present a novel screening tool to evaluate the effects of GC on Primary Care Physicians (PCP), GC nurses, and practice staff. Advantages include:

Technical Details:

Johns Hopkins researchers have developed a questionnaire to assess the effects of GC on PCPs, GC nurses, and practice staff regarding their satisfaction practicing GC, efficiency of patient care, and office moral, useful to optimize chronic patient health management. To date, peoples rising life expectancy is accompanied by increasing frequencies of chronically ill elderly people, which can be addressed by guided care, a comprehensive individualized health care model involving a close partnership between a specially-educated registered nurse with PCPs and connected caregivers (license is available at mx.com\gccm). To monitor and evaluate the efficiency of GC, researchers have created a GC survey consisting of 7 surveys of physicians, 3 surveys of GC nurses, and 3 surveys of office practice staff. Questions are intended to determine the health professionals impressions of the efficacy of GC as compared to usual care of elderly chronic patients, and possible concerns about practicing GC. Further, the survey inquires about the work moral and satisfaction with the interaction and coordination of the involved health providers. Together, this presents a valuable screening instrument to assure optimal collaboration between health care providers, beneficial for the effective personalized health care of chronic disease patients.

Looking for Partners:

To develop and commercialize the technology as a screening instrument to assess the effects of GC on health care providers.

Stage of Development:

Pre-Clinical

Data Availability:

Under CDA / NDA

Publications/Associated Cases:

J Gerontol A Biol Sci Med Sci. 2008 Mar;63(3):321-7.